Safety and efficacy of itacitinib in adults with systemic sclerosis
Safety and efficacy of itacitinib in adults with systemic sclerosis: a phase II, randomized, controlled trial - SCLERITA - SCLERITA Safety and efficacy of itacitinib in adults with systemic sclerosis: a phase II, randomized, control ...
Patients with newly or active diffuse Systemic sclerosis (SSc) at the time of screening MedDRA version: 21.0;Level: LLT;Classification code 10012977;Term: Diffuse systemic sclerosis;System Organ Class: 100000004859;Therapeutic area: Diseases [C] - Immune System Diseases [C20] Patients with newly or active diffuse Systemic sclerosis (SSc) at the time of screening MedDRA versi ...